A Wake-Up Call for AmbienHelena Oh
There's a range of insomnia drugs on the market, and more are on the way. That may come as good news for the tens of millions of people who suffer from sleeplessness. But maybe not for Sanofi-Aventis (SNY), maker of Ambien, the most prescribed insomnia drug.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.